Erman PEKTOK, Zehra Çağla KARAKOÇ, Ferah ECE, Zümrüt Tuba DEMİRÖZÜ, Deniz SÜHA KÜÇÜKASU, Nurcan ARAT

Sepsis and mediastinitis after heart transplantation: donor-transmitted Klebsiella infection

Kalp nakli sonrası enfeksiyonların erken tanı ve tedavisi prognoz için belirleyici bir faktördür. Ancak bu olgularda tanı, immün süpresyon kaynaklı müphem klinik belirtiler ve belirli bir özellik göstermeyen laboratuvar bulguları nedeniyle kolayca atlanabilir. Bu yazıda, kalp nakli sonra- sında donör kaynaklı bakteriyel enfeksiyon gelişen bir olgu ve bu klinik tablonun sonuçları sunuldu

Kalp nakli sonrası sepsis ve mediastinit: Donör kaynaklı Klebsiella enfeksiyonu

Early diagnosis and treatment of infection following heart transplantation is a determinant factor for the prognosis. However, it may easily be overlooked because of vague clinical signs and non-specific laboratory findings as a result of immunosuppression in these patients. Herein, we present a case of donor-transmitted bacterial infection after heart transplantation and its consequences

PDF

___

1. Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbels F, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011. J Heart Lung Transplant 2011;30:1078-94.
2. Montoya JG, Giraldo LF, Efron B, Stinson EB, Gamberg P, Hunt S, et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 2001;33:629-40.
3. Burket JS, Chenoweth CE, Meyer TL, Barg NL. Donor-torecipient transmission of bacteria as an unusual cause of mediastinitis in a heart transplant recipient. Infect Control Hosp Epidemiol 1999;20:132-3.
4. Grossi EA, Culliford AT, Krieger KH, Kloth D, Press R, Baumann FG, et al. A survey of 77 major infectious complications of median sternotomy: a review of 7,949 consecutive operative procedures. Ann Thorac Surg 1985;40:214-23.
5. Paul M, Raz A, Leibovici L, Madar H, Holinger R, Rubinovitch B. Sternal wound infection after coronary artery bypass graft surgery: validation of existing risk scores. J Thorac Cardiovasc Surg 2007;133:397-403.
6. Baillot R, Cloutier D, Montalin L, Côté L, Lellouche F, Houde C, et al. Impact of deep sternal wound infection management with vacuum-assisted closure therapy followed by sternal osteosynthesis: a 15-year review of 23,499 sternotomies. Eur J Cardiothorac Surg 2010;37:880-7.
7. Braxton JH, Marrin CA, McGrath PD, Ross CS, Morton JR, Norotsky M, et al. Mediastinitis and long-term survival after coronary artery bypass graft surgery. Ann Thorac Surg 2000;70:2004-7.
8. Lammermeier DE, Sweeney MS, Haupt HE, Radovancevic B, Duncan JM, Frazier OH. Use of potentially infected donor hearts for cardiac transplantation. Ann Thorac Surg 1990;50:222-5.
9. Kubak BM, Gregson AL, Pegues DA, Leibowitz MR, Carlson M, Marelli D, et al. Use of hearts transplanted from donors with severe sepsis and infectious deaths. J Heart Lung Transplant 2009;28:260-5.
10. The International Society for Heart and Lung Transplantation guidelines for the care of heart transplant patients. Task Force-1: Peri-operative care of the heart transplant recipient. Available from http://www.ishlt.org. [Accessed: May 31, 2012]
11. Ison MG. Donor-derived infections after cardiothoracic transplantation. ISHLT Monograph Series. Diagnosis and Management of Infectious Diseases in Cardiothoracic Transplantation and Mechanical Circulatory Support. Vol. 5. Philadelphia: Elsevier; 2011. p. 77-82.